Top 12 Analyst Upgrades and Downgrades: Calpine, CME, CVS, Panera and More
Investors and traders are usually on the lookout for new research ideas that will generate higher income or more profits. 24/7 Wall St. reviews many analyst research calls from Wall Street and from boutique firms to find great ideas in value stocks, growth stocks and dividend stocks. Some are stocks to buy, while some ideas are even stocks to sell. These are ten of the top analyst upgrades, downgrades, and initiations seen from select Wall Street research calls this Friday.
Boston Scientific Corp. (NYSE: BSX) was started with a Neutral rating at Wedbush.
Calpine Inc. (NYSE: CPN) was raised to Buy from Hold with a $23 price target at Deutsche Bank.
Cheniere Energy Partners L.P. (NYSEMKT: CQP) was raised to Overweight from Equal Weight at Barclays.
CME Group Inc. (NASDAQ: CME) was raised to Market Perform from Underperform at KBW.
CVS Caremark Corp. (NYSE: CVS) was started as Outperform at Wells Fargo.
Dynegy Inc. (NYSE: DYN) was started as Neutral at Goldman Sachs.
HomeAway Inc. (NASDAQ: AWAY) was raised to Overweight from Neutral with a new $36 price target by Piper Jaffray.
Melco Crown Entertainment Ltd. (NASDAQ: MPEL) was started as Outperform at Oppenheimer.
Morgan Stanley (NYSE: MS) was raised to Buy from Hold at Deutsche Bank.
Myriad Genetics Inc. (NASDAQ: MYGN) was cut to Hold from Buy at Jefferies.
Panera Bread Co. (NASDAQ: PNRA) was cut to Neutral from Buy at Lazard Capital.
Tiffany & Co. (NYSE: TIF) was started as Outperform at Credit Suisse.